Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis

Affiliations

• ¹ Department of Dermatology, Rouen University Hospital, Rouen, France. Electronic address: [email protected].
• ² Department of Dermatology, Caen University Hospital, Caen, France.
• ³ Department of Neurology, Caen University Hospital, Caen, France.
• ⁴ Department of Dermatology, APHP Saint Louis Hospital, Paris, France.
• ⁵ Department of Dermatology, APHP Saint Louis Hospital, Paris, France; Université Paris 7 Diderot, Sorbonne Paris Cité, Paris, France.
• ⁶ Université Paris 7 Diderot, Sorbonne Paris Cité, Paris, France; Department of Neurooncology, APHP Saint Louis Hospital, Paris, France.